We are live on ! Find out more
SCM

Stonebridge Capital Management Portfolio holdings

AUM $220M
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$20.2M
Cap. Flow
-$28.1M
Cap. Flow %
-11.07%
Top 10 Hldgs %
38.34%
Holding
155
New
6
Increased
10
Reduced
81
Closed
12

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.11M
2
DVA icon
DaVita
DVA
+$579K
3
ALC icon
Alcon
ALC
+$234K
4
UPS icon
United Parcel Service
UPS
+$207K
5
FITB
Fifth Third Bancorp
FITB
+$207K

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.51M
2
GILD icon
Gilead Sciences
GILD
+$1.47M
3
DIS icon
Walt Disney
DIS
+$1.21M
4
NVS icon
Novartis
NVS
+$998K
5
MSFT icon
Microsoft
MSFT
+$982K

Sector Composition

Rank Sector Weight
1 Technology 26.55%
2 Healthcare 17.46%
3 Industrials 11.58%
4 Consumer Staples 9.42%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SI
51
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$976K 0.38%
16,389
+60
+0.4% +$3.57K
DVN icon
52
Devon Energy
DVN
$51.3B
$962K 0.38%
33,725
-14,275
-30% -$424K
AMAT icon
53
Applied Materials
AMAT
$347B
$894K 0.35%
19,900
– –
BLK icon
54
Blackrock
BLK
$167B
$886K 0.35%
1,889
-817
-30% -$370K
ABBV icon
55
AbbVie
ABBV
$465B
$880K 0.35%
12,107
– –
NSC icon
56
Norfolk Southern
NSC
$75.4B
$871K 0.34%
4,370
– –
FLR icon
57
Fluor
FLR
$6.54B
$859K 0.34%
25,513
-2,800
-10% -$93.8K
UN
58
DELISTED
Unilever NV New York Registry Shares
UN
$852K 0.34%
14,025
-76
-0.5% -$4.55K
RDS.B
59
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$847K 0.33%
12,894
– –
LLL
60
DELISTED
L3 Technologies, Inc.
LLL
$821K 0.32%
3,348
– –
IVZ icon
61
Invesco
IVZ
$12.4B
$715K 0.28%
34,925
-34,165
-49% -$709K
K
62
DELISTED
Kellanova
K
$707K 0.28%
14,058
-4,739
-25% -$252K
MLM icon
63
Martin Marietta Materials
MLM
$34.2B
$659K 0.26%
2,865
-1,410
-33% -$305K
SNY icon
64
Sanofi
SNY
$107B
$624K 0.25%
14,406
-6,650
-32% -$283K
COST icon
65
Costco
COST
$432B
$612K 0.24%
2,315
– –
GSK icon
66
GSK
GSK
$107B
$602K 0.24%
12,043
-3,320
-22% -$167K
NVDA icon
67
NVIDIA
NVDA
$4.6T
$529K 0.21%
128,800
-26,200
-17% -$109K
AMGN icon
68
Amgen
AMGN
$209B
$525K 0.21%
2,847
– –
AVY icon
69
Avery Dennison
AVY
$12.8B
$515K 0.2%
4,454
-175
-4% -$19.1K
HON icon
70
Honeywell
HON
$76.4B
$506K 0.2%
3,077
-265
-8% -$42.2K
AXP icon
71
American Express
AXP
$224B
$499K 0.2%
4,040
– –
NEE icon
72
NextEra Energy
NEE
$185B
$497K 0.2%
9,696
– –
META icon
73
Meta Platforms (Facebook)
META
$1.49T
$494K 0.19%
2,557
-2,590
-50% -$473K
UNP icon
74
Union Pacific
UNP
$174B
$478K 0.19%
2,825
-25
-0.9% -$4.28K
AMD icon
75
Advanced Micro Devices
AMD
$700B
$449K 0.18%
14,775
-6,675
-31% -$190K
1 2
3
4 5

Similar funds

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
RM
Radcliff Management New York $220M AUM 22.57% 1-Year Est. Return
DA
DCM Advisors New York $220M AUM 23.37% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
LPP
Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return
AWM
Aberdeen Wealth Management Lake Bluff, Illinois $219M AUM 16.64% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $219M AUM 19.72% 1-Year Est. Return
FA
Financial Avengers Oakland, California $219M AUM 26.12% 1-Year Est. Return

Stonebridge Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Stonebridge Capital Management held 155 positions worth $254M, down 7.4% from $274M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stonebridge Capital Management withdrew a net $28.1M in Q2 2019, closing 12 positions and reducing 81 holdings. Its most notable exit was Biogen, an estimated $634K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Stonebridge Capital Management opened a new position in Alcon worth $247K.

  • Stonebridge Capital Management's largest Q2 2019 buy was Alcon: 3,988 shares worth $247K.
  • Stonebridge Capital Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $1.11M increase.
  • Stonebridge Capital Management's biggest Q2 2019 reduction was Starbucks, cutting an estimated $1.51M.
  • Stonebridge Capital Management fully exited Biogen in Q2 2019, selling an estimated $634K.
  • Stonebridge Capital Management's ten largest holdings make up 38% of its $254M portfolio in Q2 2019.
  • Stonebridge Capital Management opened 6 new positions and closed 12 in Q2 2019.
  • Stonebridge Capital Management's portfolio value fell 7.4% quarter-over-quarter to $254M.

Based on Stonebridge Capital Management's 13F filing for Q2 2019, filed 12 Jul 2019.